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Abstract
Background: Multi-walled carbon nanotubes (MWCNT) are new manufactured nanomaterials with a wide
spectrum of commercial applications. The durability and fiber-like dimensions (mean length 3.9 μm long × 49 nm
diameter) of MWCNT suggest that these fibers may migrate to and have toxicity within the pleural region. To
address whether the pleura received a significant and persistent exposure, C57BL/6J mice were exposed by
pharyngeal aspiration to 10, 20, 40 and 80 μg MWCNT or vehicle and the distribution of MWCNT penetrations
determined at 1, 7, 28 and 56 days after exposure. Following lung fixation and sectioning, morphometric methods
were used to determine the distribution of MWCNT and the number of MWCNT fiber penetrations of three
barriers: alveolar epithelium (alveolar penetrations), the alveolar epithelium immediately adjacent to the pleura
(subpleural tissue), and visceral pleural surface (intrapleural space).
Results: At 1 day 18%, 81.6% and 0.6% of the MWCNT lung burden was in the airway, the alveolar, and the
subpleural regions, respectively. There was an initial, high density of penetrations into the subpleural tissue and the
intrapleural space one day following aspiration which appeared to decrease due to clearance by alveolar
macrophages and/or lymphatics by day 7. However, the density of penetrations increased to steady state levels in
the subpleural tissue and intrapleural from day 28 - 56. At day 56 approximately 1 in every 400 fiber penetrations
was in either the subpleural tissue or intrapleural space. Numerous penetrations into macrophages in the alveolar
airspaces throughout the lungs were demonstrated at all times but are not included in the counts presented.
Conclusions: The results document that MWCNT penetrations of alveolar macrophages, the alveolar wall, and
visceral pleura are both frequent and sustained. In addition, the findings demonstrate the need to investigate the
chronic toxicity of MWCNT at these sites.
Background
Carbon nanotubes (CNT) are nanometer diameter tubes
of pure carbon which are being developed and produced
in mass quantities for a variety of applications such as
strengthening of composite materials, ballistics fabrics,
medical imaging, drug delivery and as a key component in
lithium batteries. CNT production is estimated to reach
into the millions of tons [1]. Many variations on the form,
end configuration and number of concentric shells or
tubes of the carbon atoms are actively being developed
with single-walled carbon nanotubes (SWCNT) and
multi-walled carbon nanotubes (MWCNT) being the two
principal forms.
Due to the physical and chemical durability and
fibrous shape of MWCNT, concern has been raised that
MWCNT may exhibit potentially significant health
hazards similar to asbestos [2]. A recent report demon-
strates that intraperitoneal instillation of MWCNT in
p53 +/- mice results in mesothelioma [3]. This study
has been questioned due to the high dose of MWCNT
(3 mg) injected into the abdomen [4]. However, a follow
up preliminary report from the same group demon-
strated mesothelioma also occurred after intraperitoneal
injection of as little as 50 μg/mouse [5]. Abdominal and
thoracic mesothelioma was also reported after intrascro-
tal injection of MWCNT into Fischer rats [6]. Poland
et al [7] reported that intraperitoneal injection of 50 μg
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inflammation and granulomatous lesions on the abdom-
inal side of the diaphragm at 1-2 weeks post-exposure.
In contrast, Muller et al. [8] reported no mesothelioma
2 years after intraperitoneal injection of MWCNT. How-
ever, the MWCNT sample used in this study consisted
of very short fibers (<1 μm), which would have been
predicted by Poland and coworkers to exhibit low bioac-
tivity in that assay. Although the data above indicate
that MWCNT can cause mesothelioma after intraperito-
neal instillation, as does asbestos, data are required that
MWCNT actually come in contact with the mesothelial
cells lining the lung after pulmonary exposure. A review
by Donaldson et al. [9] argues that migration into the
intrapleural space is common for particles deposited in
the distal lung. However, risk assessment requires evi-
dence that MWCNT not only can reach the intrapleural
space but quantification of the dose-dependence and
time course of such migration.
The multiple concentric walls of carbon in MWCNT
are substantially more rigid than SWCNT and are
found to penetrate and/or pass through cells and
membranes in the exposed lungs. We have previously
reported the extensive degree to which lungs respond
to MWCNT, including the rapid development of pul-
monary fibrosis by 7 days post-exposure and the
formation of granulomatous lesions [10,11]. In that
study, MWCNT were observed to reach the pleura
after pulmonary exposure. This result is supported by
Ryman-Rasmussen et al. [12] who reported that
MWCNT can reach the subpleural tissue after inhala-
tion. In order to conduct an evaluation of this poten-
tial hazard, further study is necessary. Determination
of the proportion of the lung burden which is trans-
ported to the pleura, the time-course of the transport,
and finally the dose-response of tissues in the pleura
which are exposed to the transported MWCNT, should
be determined. The present study was designed to
extend the initial observations by measurement of
MWCNT migration to the subpleural tissue and intra-
pleural space at different lung burdens and determina-
tion of the time course of that transport.
Results
The light microscopic section of Figure 1 shows a
representative cross-section from terminal bronchiole
out to the pleural surface of the lungs 1 day after
aspiration of a 80 μg dose. As illustrated in the micro-
graph, MWCNT were deposited throughout the alveolar
region of the lungs with the highest concentrations visi-
ble in the alveoli immediately proximal to the terminal
bronchiole.
Figure 1 Light micrograph of MWCNT deposition in alveolar region of lungs. Sirius Red stained micrograph showing the general
deposition pattern of MWCNT (arrows) one day after aspiration. A deposit of MWCNT on the epithelium of the terminal bronchiole (TB) near the
transition between the airways and the alveolar region is indicated by the asterisk. Smaller deposits near the subpleural tissue region are
indicated by double arrows. (dose 80 μg).
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post-aspiration (80 μg) is shown in Figure 2. The results
demonstrate the prominent role of alveolar macro-
phages. The majority of the lung burden was deposited
in the alveolar region with alveolar macrophages receiv-
ing 62% of the total dose. The airways and alveolar
regions accounted for 18 and 81% of the lung burden,
respectively. MWCNT in the visceral pleura region (sub-
pleural tissue and intrapleural space) accounted for
approximately 0.6% of the total lung burden.
A representative image of the granulomatous lesions
formed by MWCNT 56 days after aspiration of a
20 μg dose is shown in Figure 3. Collagen fibers in this
section are stained in red. The section illustrates the
highly fibrotic nature of the lung response to well
dispersed MWCNT. These fibrotic nodules were rare
in number compared to similar lesions previously
reported for poorly dispersed SWCNT [13-15]. These
earlier studies with SWCNT did not use dispersants in
the media, resulting in many densely packed, 15-20
micron diameter clumps of SWCNT in the lungs
immediately following exposure. The lung response to
such large, “foreign” bodies is to wall-off the material
with epitheloid macrophages resulting in the promi-
nent granulomas illustrated in studies that rely solely
on mechanical means to disperse SWCNT [13-15]. Use
of a well-dispersed preparation of SWCNT has been
shown to decrease granuloma formation and enhance
the diffuse interstitial fibrotic response from the sub-
micron SWCNT [16].
The FESEM micrograph of Figure 4 demonstrates the
direct penetration of an alveolar Type I epithelial cell by
multiple MWCNT one day after an 80 μgd o s e .T h e
penetration process was rapid and observed to be most
frequent for alveolar macrophages followed by alveolar
Type I epithelial cells and to a lesser extent by alveolar
interstitial cells which were typically penetrated by a
fiber as it passed through an adjacent epithelial cell. The
FESEM observations confirmed the prior light micro-
scopy based observations that MWCNT frequently
extend from the cell surface through cell nuclei as well
as other organelles and were not confined to phagolyso-
somes [10]. Alveolar Type II epithelial cells, which
account for 2% of the normal epithelial surface [17],
were rarely found to have penetrations by MWCNT.
MWCNT could be observed in the mucous lining layers
a b o v ea i r w a ye p i t h e l i a lc e l l sa n di na i r w a ym a c r o p h a g e s
contained in the cilia-mucous lining layer of the airways
but penetrations by MWCNT were rarely observed.
Based on the morphometric analysis, there were sub-
stantial number of alveolar epithelial cells penetrations
by MWCNT (Figure 5). A normal mouse lung contains
11 million alveolar Type I epithelial cells [17] and there
were 15 million MWCNT penetrations observed at the
20 μg dose. Thus at this dose, on average, every Type I
epithelial cell would have approximately one and half
MWCNT penetration. We did not determine the num-
ber of alveolar macrophage penetrations as the number
and degree of overlap by multiple penetrations were too
great to make accurate counting of individual penetra-
tions practical. There are approximately 3 million alveo-
lar macrophages in the normal mouse lung [17] and the
alveolar macrophage lung distribution of MWCNT was
approximately 6 times that of the tissue (Figure 2).
Thus, there are one third the cell number receiving 6
times the dose. This which would indicate that the
alveolar macrophage penetrations might be 18-fold
higher than the alveolar epithelial dose per cell or 27
MWCNT penetrations per alveolar macrophage at the
20 μg dose. The number of MWCNT penetrations per
lung versus aspiration dose of MWCNT demonstrated a
sigmoidal dose-response with an ED50 of 15.3 μg.
Lung fixation in-situ followed by removal of the lungs
from the chest cavity was used to obtain lung tissue in
this study. This method does not preserve the contents
of the pleural space. In order to preserve the pleural
space contents special methods, such as interpleural
injection of agarose, are required [18]. However, intra-
lobular septa are relatively undisturbed by the fixation
technique used in our study and intralobular septa were
found to contain MWCNT within macrophages as
shown by the representative photomicrograph (Figure 6)
which was taken at 56 days post-aspiration of a 40 μg
dose. The presence of MWCNT loaded macrophages in
Figure 2 Morphometric determination of the initial lung
distribution of MWCNT 1 day post aspiration. Results show the
distribution of MWCNT fiber burden in airways, alveolar and
subpleural tissue regions of the lungs one day after aspiration. As
shown by the different shades of bars, MWCNT fiber burden in the
airways and alveolar regions were further subdivided into the
airspaces of the region, tissue of the region and macrophages.
Results are expressed as a percentage of the total lung burden.
(Mean ± SE, N = 7).
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Page 3 of 11Figure 3 Light micrograph of fibrotic granulomas 56 days following MWCNT. Micrograph illustrates the extensive collagen network
developed within granulomas that developed following a single 20 μg dose of MWCNT. Section stained with Sirius Red show collagen fibers in
red.
Figure 4 FESEM of MWCNT penetration of alveolar epithelial cells. As shown in this micrograph, MWCNT were rapidly incorporated into the
alveolar epithelium. Micrograph shows two MWCNT passing through an alveolar epithelial cell 1 day after aspiration (80 ug dose). The two fibers
are running together on the right side of the cell and appear to separate within the cell as they pass out on the left side of the cell. Another
MWCNT penetrates the epithelium in the upper right of micrograph.
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port to the pleural space.
Figure 7 provides micrographic examples of the var-
ious types of MWCNT penetrations observed in the
visceral pleura and immediate adjacent subpleural tis-
sues. The visceral pleural surface runs along the top in
each micrograph with a clear visualization of the abun-
dant microvilli of mesothelial cells in Figure 7D. The
micrograph in Figure 7A (80 μg, 28 days) shows both a
MWCNT-loaded alveolar macrophage and a single
MWCNT fiber penetrating into the subpleural tissues.
Subpleural tissue and visceral pleural penetrations were
frequently observed in areas which also had one or
more MWCNT-loaded alveolar macrophages such as
s h o w ni nt h i sf i g u r e .T h e r ew as also significant sub-
pleural involvement and associated MWCNT penetra-
tions of the subpleural lymphatics as illustrated by
Figure 7B (80 μg, 56 days) which shows a dilated sub-
pleural lymphatic with several MWCNT penetrating a
mononuclear inflammatory cell within the lymphatic
vessel. The light micrograph of Figure 7C (80 μg, 28
days) captures a MWCNT penetration into the intra-
pleural space (right arrow). An alveolar macrophage
loaded with MWCNTs is also in the field of view (left
arrow). The FESEM of Figure 7D (80 μg, 56 days) shows
a MWCNT penetrating the mesothelial surface of the
visceral pleura, through the mesothelial cell layer with
the fiber ending in the alveolar region. The microvilli of
the pleural mesothelial cells which are particularly elon-
gated in the visceral pleura are evident in this view [19].
Measurements of the number of MWCNT fiber pene-
trations into subpleural tissue and intrapleural space at
different doses of MWCNT are given in Figure 8. No
intercepts of subpleural tissue by MWCNTs were
detected at the lowest dose of 10 μg while at the higher
dose of 80 μg there were 11,900 penetrations of the sub-
pleural tissue per lung and 5,980 penetrations into the
intrapleural space of the lungs.
The time course of fiber penetrations into the sub-
pleural tissue and into the pleural surface is given in
Figure 9. One day post aspiration there were substantial
fiber penetrations with some initial clearance, evident by
the decline at 7 days. By 7 days the number of sub-
pleural tissue penetrations declined to approximately
20% of the subpleural tissue penetrations at one day.
Following the initial decline between day 1 and 7, the
number of subpleural and intrapleural space penetra-
tions increased at the longer time points of 28 and 56
days.
Discussion
Animal studies of MWCNT toxicity have generally
found evidence for an acute inflammatory phase lasting
approximately 7 days with chronic and persistent Type
II cell hyperplasia, progressive fibrotic thickening of the
alveolar wall and a varying size and extent of granulo-
matous inflammation depending on how well dispersed
the MWCNT were during exposure [10,20-23]. These
chronic effects have been shown to persist out to 91
days and are qualitatively similar to those observed for
SWCNT [24].
Given the similarity in time-course and types of
responses to SWCNT versus MWCNT, it might be
assumed that the two CNTs react similarly in tissues.
However, examination of lung tissues, particularly with
high resolution FESEM or TEM, demonstrates that
Figure 5 Morphometric determination of the number of
alveolar epithelial penetrations versus dose 56 days after
aspiration. The number of MWCNT penetrations per lung versus
aspiration dose of MWCNT demonstrated a sigmoidal dose-response
with an ED50 of 15.3 μg. (Mean ± SE, N = 8).
Figure 6 Photomicrograph of lung section showing an
intralobular septum. This micrograph shows several MWCNT
loaded macrophages (arrows) in the intralobular septum at 56 days
post aspiration (40 μg dose).
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distinct from those of SWCNT. When highly dispersed
into submicron structures SWCNT do not form granu-
lomatous lesions but instead are incorporated into the
interstitium in a diffuse distribution throughout the
lungs. Indeed the dispersion is so extensive that indivi-
dual nanotubes are difficult to identify without being
tagged with an easily detectable label such as colloidal
gold [16]. In lungs exposed to MWCNT in our study,
the individual fibers are generally easy to identify and
can be followed as they penetrate into and/or through
cells and tissue layers (Figure 7.). In SWCNT exposed
lungs only a small percentage of SWCNT structures
were found in alveolar macrophages [16]. In contrast,
alveolar macrophages in MWCNT-exposed lungs
contained numerous MWCNT. Many of the MWCNT
penetrations traverse completely through the cell and/or
cell nucleus [10]. The fiber load within alveolar macro-
phages was approximately 62% of the total lung burden
at day 1 post-exposure.
T h ep e n e t r a t i o n sb yM W C N Tw e r en o tl i m i t e dt o
phagocytic cells. As shown by the results of this study,
there are high frequency penetrations in both the alveo-
lar epithelium and visceral pleura. The alveolar epithelial
cell penetrations of Figure 5 show in excess of 20 mil-
lion penetrations throughout the lungs at a dose of 40
μg or greater.
It was originally expected that the penetrations of the
subpleural tissue would follow a similar time and dose
response as the alveolar epithelial cell penetrations. This
Figure 7 Representative micrographs of MWCNT in subpleural tissues, visceral pleura and pleural space. In all four panels, the visceral
pleural surface runs along the top of each micrograph. The FESEM image in A shows a MWCNT loaded alveolar macrophage in an alveolus
immediately beneath the visceral pleura surface. The right side of the image shows a single MWCNT fiber penetrating the alveolar epithelium
into the subpleural tissues (80 μg dose, 28 day post-aspiration). Figure 7B shows a dilated subpleural lymphatic vessel which contains a
mononuclear inflammatory cell that is penetrated by several MWCNT fibers (80 μg dose, 56 day post-aspiration). A MWCNT penetrating the
visceral pleura is shown in the light micrograph of 7C with a MWCNT-loaded alveolar macrophage visible in the left side of the micrograph (80
μg dose, 28 day post-aspiration). A single MWCNT penetrating from the subpleural tissue through the visceral pleura into the pleural space is
shown in the FESEM image of 7 D (80 μg dose, 56 day post-aspiration).
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mechanism by which the alveolar epithelium was pene-
trated with the only difference being that the subpleural
tissue was by definition alveolar epithelium immediately
below the visceral pleural. The results of Figure 5 and
Figure 8 demonstrate that these two epithelial bound-
aries are not penetrated by MWCNT in the same time
versus dose response. There were significant numbers of
subpleural and intrapleural penetrations at 20, 40 and
80 μgd o s e sp e rl u n g( F i g u r e8 ) .H o w e v e r ,t h e r ew e r e
essentially none observed at the lowest dose of 10 μg
used in the study. At the same time the alveolar epithe-
lial cell penetrations at the lowest dose were 20% of
those observed at 80 μg (Figure 5).
It is possible that macrophage clearance of fibers at
the 10 μg dose was sufficient to protect the most distal
lung regions such as the pleura. However, it seems unli-
kely that this is the case given the high levels of epithe-
lial penetrations elsewhere at this dose. The differences
in transport to the two regions indicate that MWCNT
penetration of the visceral pleura is distinct from
MWCNT penetration of the alveolar epithelium that
occurs elsewhere in the lungs. It has been suggested
that dilated subpleural lymphatics may attract macro-
phage containing phagocytized MWCNT to the sub-
pleural tissue [10].
Donaldson et al. [9] argue that fiber length is critical
to the development of pleural pathology, since short
fibers should be cleared from the intrapleural space via
ducts in the parietal pleura which drain into the lym-
phatics. The length of MWCNT used in the present
study is 3.9 μm [10]. Given this length, it would be
expected that MWCNT would be cleared from the
intrapleural space via these ducts [9]. Such clearance
was observed from 1 to 7 days post aspiration. However,
intrapleural levels of MWCNT rose once again at 28
days and remained constant through 56 days post
aspiration. It is possible that the lung burden of
M W C N Ta c t sa sar e s e r v o i rt or e p l e n i s hM W C N Ti n
the intrapleural space. It is also possible that the 3.9 μm
fibers could reach a level within the intrapleural space
at which ducts begin to be clogged. NIOSH is currently
conducting a 12 day inhalaton study for MWCNT with
an evaluation period as long as 1 year post-exposure
which should elucidate issues concerning long-term
kinetics of penetration vs clearance of MWCNT from
the intrapleural space.
In this study we have demonstrated rapid and direct
transport of MWCNT to the visceral pleura (Figures 2,
7, 8 and 9). Ryman-Rasmussen et al. [12] and our own
laboratory group [10,11] have reported deposition of
MWNCT in the subpleural tissue after inhalation or
aspiration exposure. However, to our knowledge there
are no available data on nanomaterial penetrations of
pleura. Transport of man-made mineral fibers to the
pleura have been reported. Gelzleichter et al. [25] found
transport of 0.09% of the lung burden to the rat pleura
following a 12 day exposure at 83 mg/m
3 to refractory
ceramic fiber (RCF-1). Bermundez et al. [18] exposed
Figure 8 Effect of MWCNT dose on MWCNT fiber penetrations
into subpleural tissue and intrapleural space 56 days after
aspiration. This figure shows the number per lung for fibers which
penetrated into the subpleural tissue and for fibers which
penetrated into the intrapleural space. As indicated by the asterisks,
both the number of subpleural tissue and intrapleural space
penetrations at 80 μg were different from the corresponding
subpleural tissue and intrapleural space penetrations at doses of 10,
20 and 40 μg. (Mean ± SE, N = 8).
Figure 9 Time course of MWCNT penetrations into the
subpleural tissue and intrapleural space. There was a significant
number of penetrations into the subpleural tissue and intrapleural
space with an initial spike at one day after aspiration with some
initial clearance evident by the decline at 7 days. However the
number of penetrations in both spaces significantly increased after
day 7 and was still elevated 56 days after the initial aspiration. Data
from animals given a single aspiration dose of 80 μg. As indicated
by the asterisk, the number of subpleural tissue penetrations at 1
day was significantly different from the number of penetrations at 7,
28 and 56 days. (Mean ± SE, N = 8).
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fibers (85 mg/m
3). They reported 5% and 0.5% of the
total lung fiber burden (between 1 and 8 μmi nl e n g t h )
was transported to the pleural surface of the hamster
and rat, respectively. While not directly comparable due
to species differences and the obvious larger size of
the synthetic fiber, our result demonstrating a 0.6%
transport 1 day following the aspiration of 80 μgo f
M W C N Ti sw i t h i nt h ew i d er a n g er e p o r t e db yt h e s e
studies (Figure 2).
In the case of human exposures, fiber burdens have
been evaluated in workers from a number of different
occupational exposures settings. As indicated by Miser-
occi et al. [26], evaluation of human lung tissue from
individuals exposed to asbestos is difficult to conduct
due to the decades of life over which asbestos transloca-
tion occurs. Typically, human studies involve detailed
measurements of the length and types of asbestos fibers
in ashed or digested samples of lung parenchyma and
pleura which are fibrotic in nature as these are more
likely to contain asbestos fibers [27]. Suzuki and
Kohyama [28] reported on a study of 13 insulators that
fibrotic lung areas contained 64 x10
6 chrysotile fibers/g
d r yw e i g h t( w t )a n d1 5 0x 1 0
6 amosite fibers/g dry wt
while pleural tissue samples contained 46 x10
6 chrysotile
fibers/g dry wt and 2.2 x10
6 amosite fibers/g dry wt. The
transfer of asbestos fibers from the parenchyma to the
intrapleural space can not be estimated without data on
the relative masses of fibrotic lung areas and affected
pleural sites. These masses would likely vary consider-
ably depending on the exposure and stage of the disease.
However, even assuming a ratio of 250 to 1 (the ratio of
human alveolar surface area [17] to pleural surface area
[29]) between mass of fibrotic lung area and mass of
affected pleural sites would suggest a considerable trans-
port to the pleural space. Experimental animal studies of
chrysotile or amosite asbestos inhalation have had mixed
conclusions on the extent to which asbestos fibers are
transported to the pleura [30,31]. Even after 6 months
of amosite exposure in hamsters, Hesterber et al [30]
referred to the “occasional” penetration of the pleura by
asbestos although all bronchioles in the lungs were
affected at that advanced stage.
Conclusions
In summary, the results of this study demonstrate that
MWCNT penetrations of alveolar macrophages, the
alveolar epithelium, and pleura are rapid, frequent
and persistent. There is an acute phase clearance of
MWCNT from the subpleural tissue which is likely due
to macrophage and subpleural lymphatic activity, while
acute clearance of MWCNT may involve flow of intra-
pleural fluid through stromal pores on the surface of the
parietal pleura [9,27]. At 28 days post-exposure, an
equilibrium is reached between this clearance and
replenishment of intrapleural MWCNT from subpleural
tissue. Available data on asbestos lung burden transport
to the pleural space is incomplete but suggests that the
significant and rapid transport of MWCNT to the intra-
pleural space may be distinctly different from the dec-
ades long process identified in asbestos exposed
humans. In humans, the risk of mesothelioma develop-
ment are the consequence of chronic exposure and
chronic response to fibers. Results from the current
acute study of a bolus aspiration of MWCNT are thus
not directly comparable.
Methods
Animal
Male C57BL/6J mice (7 weeks old) were obtained from
Jackson Laboratories (Bar Harbor, ME). Mice were
housed one per cage in polycarbonate ventilated cages,
which were provided HEPA-filtered air, with fluorescent
lighting from 0700 to 1900 hours. Autoclaved Alpha-Dri
virgin cellulose chips and hardwood Beta-chips were
used as bedding. Mice were monitored to be free of
endogenous viral pathogens, parasites, mycoplasms,
Helicobacter and CAR Bacillus. Mice were maintained
on Harlan Teklad Rodent Diet 7913 (Indianapolis, IN),
and tap water was provided ad libitum. Animals were
allowed to acclimate for at least 5 days before use. All
animals used in this study were housed in an AAALAC-
accredited, specific pathogen-free, environmentally con-
trolled facility. All animal procedures were approved by
the NIOSH ACUC.
Carbon Nanotube Source
MWCNT used in this study were obtained from Mitsui &
Company (XNRI MWNT-7, lot #05072001K28) and were
fully characterized in a previous report [10]. Briefly,
MWCNT trace metal contamination was 0.78% with
sodium (41%) and iron (0.32%) being the major metal
contaminants. MWCNT median length was 3.86 μma n d
count mean diameter of 49 ± 13.4 (S.D.)nm.
Pharyngeal Aspiration of MWCNT
Suspensions of MWCNT for aspiration were prepared in
a dispersion medium (DM) as reported previously [32].
Dispersion medium was made up of Ca
+2 and Mg
+2
phosphate-buffered saline (PBS), pH 7.4, supplemented
with 5.5 mM D-glucose, 0.6 mg/ml mouse serum albu-
min and 0.01 mg/ml 1,2 dipalmitoyl-sn-glycero-3-phos-
phocholine (DPPC) DPPC was prepared fresh as a 10
mg/ml stock solution in absolute ethanol. DM has been
s h o w nt ob ea ne f f e c t i v ed i s persing agent for multi-
walled carbon nanotubes and does not elicit toxicity
[32,33]. Recently published direct comparisons studies
between inhalation and aspiration of SWCNT have
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technique for such studies [24].
Mice were anesthetized with isoflurane (Abbott
Laboratories, North Chicago, IL) for pharyngeal aspira-
tion. When fully anesthetized, the mouse was positioned
with its back against a slant board and suspended by the
incisor teeth using a rubber band. The mouth was
o p e n e d ,a n dt h et o n g u eg e n t l yp u l l e da s i d ef r o mt h e
oral cavity. A 50 μl aliquot of sample was pipetted at
t h eb a s eo ft h et o n g u e ,a n dt h et o n g u ew a sr e s t r a i n e d
until at least 2 deep breaths were completed (but for
not longer than 15 seconds). Following release of the
tongue, the mouse was gently lifted off the board, placed
on its left side, and monitored for recovery from
anesthesia. In order to eliminate the possibility of inci-
dental food aspiration, food was removed 4 hours prior
to the procedure; water was removed 1 hour prior. This
alternative to inhalation has been shown to produce a
similar distribution of lung burden to that following
inhalation and has been described in detail elsewhere
[34]. Mice received either DM (vehicle control), 10, 20,
40 or 80 μg MWCNT.
At 1, 7, 28 and 56 days after aspiration, mice were
euthanized by an overdose of pentobarbital (>100 mg/kg
body weight, i.p.) followed by transection of the abdom-
inal aorta to provide exsanguination. Seven to 8 animals
were studied at each time point. The lungs were fixed
by intratracheal perfusion with 1 ml of 10% neutral buf-
fered formalin after 30 minutes the lungs were removed
from the chest cavity. Lungs were trimmed the same
day, processed overnight in a tissue processor, and
embedded in paraffin.
For morphometric studies, paraffin sections of the left
lung (5 μm thick) were cut. A new region of the disposa-
ble knife blade was used to section each block in order to
prevent potential cross-contamination that might result
from MWCNT passage on the knife between sections.
The sections were then deparaffinized and rehydrated
with xylene-alcohol series to distilled water. To enhance
the contrast between tissue and MWCNT, lung sections
were stained with Sirius Red [35]. Sirius Red staining
consisted of immersion of the slides in 0.1% Picrosirius
solution (100 mg of Sirius Red F3BA in 100 ml of satu-
rated aqueous picric acid, pH 2) for 1 - 2 hours followed
by washing for 1 minute in 0.01 N HCl. Sections were
then briefly counterstained in freshly filtered Mayer’s
hematoxylin for 2 minutes, dehydrated, and mounted
with a coverslip. Additional sections were stained with
hematoxylin and eosin for routine pathology assessment
as previously reported [10].
Field Emission Scanning Electron Microscopy
For scanning electron microscopy, sections of the lung
were cut at 8 microns, placed on carbon planchets,
deparaffinized and sputter coated. After coating, the spe-
cimens were examined with a Hitachi Model S-4800
Field Emission Scanning electron microscope (FESEM)
a t5t o2 0k V .U s eo ft h i ns e c t i o n sf r o mp a r a f f i n
e m b e d d e dt i s s u ew a sf o u n dt ob ep r e f e r a b l et ol a r g e ,
unevenly cut blocks because it provided a uniform
thickness of organic material on the carbon planchet.
The 8 micron sections were thick enough to convey
three-dimensional information but were also less likely
to charge or undergo shifts when examined at the high
magnifications necessary to study nanomaterials.
Lung Distribution of MWCNT
The distribution of MWCNT in the lungs was deter-
mined by counting the occurrence of MWCNT under
an eyepiece point counting overlay using standard mor-
phometric point counting methods [36] similar to those
previously described for study of the distribution of
SWCNT [16,36]. Point counting categories were subdi-
vided into points over MWCNT in airway, points over
MWCNT in the alveolar region, and points over
MWCNT in the subpleural tissue region. Airway regions
were defined as those containing airway tissue (airway
epithelial cells-basement membrane and tissues of the
broncho-vascular cuff), airway lumen, and associated
blood vessels greater than 25 microns. Alveolar regions
were those containing alveolar tissue and alveolar air
space. The visceral pleura region included MWCNT in
the subpleural tissue and MWCNT in the pleural sur-
face. The subpleural tissue regions included the immedi-
ately subpleural alveolar interstitial-epithelium layer and
subpleural lymphatics but did not include any portion of
alveolar walls attaching to the pleura. Points in airway
and alveolar regions were further subdivided into points
over MWCNT that were in the airspace, points over
MWCNT that were in tissue of the region, and points
over MWCNT that were in macrophages.
To accomplish the counting, an eyepiece counting
overlay consisting of 11 by 11 lines (121 total points for
each throw of the overlay) was used with a 100× oil
immersion objective. A grid pattern for throws of the
counting overlay was used in order to insure a uniform
sampling of the section which did not overweight inter-
ior points. The counting overlay throws of the eyepiece
were positioned over the section at 12 uniformly spaced
grid points in both × and Y co-ordinates. These 12 grid
points were determined using the stage micrometer
scale to measure the × and Y bounds of the section.
Using the bounding rectangle of these co-ordinates a 3
by 4 grid was selected and the 12 intersections were
used as the center point for each of the eyepiece count-
ing overlay throws.
For each animal, three sections were counted and the
counts for the airways, alveolar and subpleural tissue
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divided by this total and multiplied by 100 to express
the results as a percentage of total lung burden.
Alveolar Epithelial Penetrations
Penetrations of the alveolar epithelium by MWCNT
fibers were determined by counting the number of fiber
penetrations per unit area based on repeated throws of
an eyepiece counting box overlay. To tabulate the
counts for each section, 12 placements of the eyepiece
counting box overlay were carried out using a grid pla-
cement system similar to that described for determina-
tion of the lung distribution of MWCNT. For each
placement, a count was made of the MWCNT which
penetrated the alveolar epithelium within the box. Total
penetrations per unit area of lung section were divided
by the volume of the counting box (area times thick-
ness) to obtain the number of penetrations per unit
volume which was then multiplied by the fixed lung
volume to express the results as number of alveolar
epithelial penetrations per lung. Section thickness was
5.14 μm. The section thickness was determined by tak-
ing micrometer measurements of a tissue block before
and after cutting 2000 sections. Two sections per animal
were analyzed and the results averaged. Eight animals
were analyzed per group.
MWCNT Penetrations of the Subpleural Tissue and
Intrapleural Space
For each lung section, the total number of penetrations
of MWCNT into the subpleural tissue and into the
intrapleural space was determined. Subpleural penetra-
tions were defined as MWCNT fibers which penetrated
from the alveolar air side of the pleura into the alveolar
epithelium and interstitium/subpleural lymphatics
immediately beneath the mesothelial cell layer of the
visceral pleura. In the rudimentary visceral pleura of the
normal mouse, this is essentially a 1 to 2 micron depth
below the surface of the mesothelial cells forming the
visceral pleura. Intrapleural penetrations were defined as
MWCNT fibers which penetrated the surface of the
visceral pleura. Occasionally fibers where sufficiently
long to penetrate completely from the alveolar side
through to the visceral pleural (see Figure 7 in Results).
These cases were counted as both subpleural tissue and
intrapleural penetrations.
The counting of penetrations was done by sweeping
around the pleural perimeter of the section using a
100× oil immersion objective with constant refocusing
as the complete perimeter of the visceral pleura (includ-
ing interlobular septa) was scanned. These counts were
divided by the area of the pleural surface in the cross
section (perimeter length times the section thickness) to
obtain the number of penetrations (subpleural and
intrapleural) per unit of pleural surface area. The peri-
meter length of the pleura was determined from low
magnification images digitized for each section and
measured using ImageJ. To express the results as num-
ber of penetrations per lung, the penetrations per unit
of pleural surface area were multiplied by the pleural
s u r f a c ea r e ao ft h em o u s el u n g( 5 0 0m m
3 , [29]). Cor-
rection for the potential over-estimation of counts due
to the size dependent projection of the length of the
fibers, Holmes effect [37], was not necessary as the
counts were done of the intersections between the fiber
and the surface. The area of intersection corresponds to
diameter of the fiber which is ~51 nm. This is a con-
stant factor between groups and is negligible relative to
the section thickness used for counting. Two sections
per animal were analyzed and the results averaged. Eight
animals were analyzed per group.
Statistical Analyses
Data were analyzed using analysis of variance (STAT-
GRAF). Bartlett’s test was used to test for homogeneity
of variances between groups. Statistical differences were
determined using one-way analysis of variance with sig-
nificance set at p ≤ 0.05. When significant F values were
obtained, individual means were compared to control
using Duncan’s multiple range test [38] and P < 0.05
was considered to be significant. Data are given as mean
± SE.
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